JAN

17

New antibiotics to combat multiresistant bacteria

Infectious diseases arising due to the resistance of some bacteria to the antibiotics available on the market involve a major public health problem. So much so that antimicrobial resistance causes 25,000 deaths a year in the European Union.

T...

JAN

04

The project ¨Training and social awareness for increasing organ donation in the European Union and neighbouring countries¨ (EUDONORGAN) has been launched

EUDONORGAN, acronym for ‘Training and social awareness for increasing organ donation in the European Union and neighbouring countries’ (SANTE/...

DEC

21

The Spin-off of the UB and IRB Iproteos has discovered a promising compound for the treatment of Cognitive Impairment Associated to Schizophrenia

The Catalan biotechnological company Iproteos, spin-off of the University of Barcelona and the Institute for Research in Biomedicine (IRB Barcelona), advised by Bosch i Gimpera Foundation (FBG) and with headquartered at the Barcelona Science Park (PCB)...

DEC

19

Knowledge Transfer: The financial cushion of research groups

Since 2008, the research group on immunoreceptors of the University of Barcelona, led by Dr. Pablo Engel, licences monoclonal antibodies resulting from their research to different international companies. According to Dr. Engel, this practice presents ...

DEC

19

Pilar Vinardell: «Abandoning animal testing is not only a matter of ethics, it is also cheaper»

Dr. Pilar Vinardell pioneered the search for in vitro methods as an alternative to animal experimentation in Catalonia. "These things that Pilar likes," as her colleagues in the Department of Physiology of the University of Barcelona used to ...